Decreased levels of the transcription factors Ik-1 and MZF1 contribute to upregulation of IGF-IR expression in NPM-ALK plus T-cell anaplastic large-cell lymphoma.

被引：0
|
作者：
Vishwamitra, Deeksha [1 ]
Curry, Choladda V. [2 ,3 ]
Alkan, Serhan [4 ]
Shi, Ping [5 ]
Amin, Hesham M. [1 ]
机构：
[1] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA
[2] Baylor Coll Med, Houston, TX 77030 USA
[3] Texas Childrens Hosp, Houston, TX 77030 USA
[4] Cedars Sinai Med Ctr, Los Angeles, CA 90048 USA
[5] E China Univ Sci & Technol, Shanghai 200237, Peoples R China
来源：
CLINICAL CANCER RESEARCH | 2015年 / 21卷
关键词：
D O I：
10.1158/1557-3265.HEMMAL14-A36
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
A36
引用
收藏
页数：2
相关论文
共 17 条
  • [1] The transcription factors Ik-1 and MZF1 downregulate IGF-IR expression in NPM-ALK+ T-cell lymphoma
    Deeksha Vishwamitra
    Choladda V Curry
    Serhan Alkan
    Yao-Hua Song
    Gary E Gallick
    Ahmed O Kaseb
    Ping Shi
    Hesham M Amin
    Molecular Cancer, 14
  • [2] The transcription factors Ik-1 and MZF1 downregulate IGF- IR expression in NPM- ALK+ T-cell lymphoma
    Vishwamitra, Deeksha
    Curry, Choladda V.
    Alkan, Serhan
    Song, Yao-Hua
    Gallick, Gary E.
    Kaseb, Ahmed O.
    Shi, Ping
    Amin, Hesham M.
    MOLECULAR CANCER, 2015, 14
  • [3] IGF-IR tyrosine kinase interacts with NPM-ALK oncogene to induce survival of T-cell ALK+ anaplastic large-cell lymphoma cells
    Shi, Ping
    Lai, Raymond
    Lin, Quan
    Iqbal, Abid S.
    Young, Leah C.
    Kwak, Larry W.
    Ford, Richard J.
    Amin, Hesham M.
    BLOOD, 2009, 114 (02) : 360 - 370
  • [4] In vitro and in vivo antitumor activity of the selective ALK inhibitor ASP3026 against NPM-ALK plus T-cell anaplastic large-cell lymphoma
    Vishwannitra, Deeksha
    George, Suraj Konnath
    Manshouri, Roxsan
    Shi, Ping
    Amin, Hesham M.
    CANCER RESEARCH, 2014, 74 (20)
  • [5] Sumoylation Sustains the Stability of NPM-ALK Oncogenic Protein and Facilitates Its Nuclear Accumulation in T-Cell Anaplastic Large-Cell Lymphoma
    Vishwamitra, Deeksha
    Curry, Choladda V.
    Alkan, Serhan
    Shi, Ping
    Amin, Hesham M.
    BLOOD, 2014, 124 (21)
  • [6] Trka, a Novel Binding Partner of NPM-ALK Oncogenic Tyrosine Kinase, Facilitates the Survival of T-Cell Anaplastic Large-Cell Lymphoma
    Shi, Wenyu
    George, Suraj Konnath
    Curry, Choladda V.
    Alkan, Serhan
    Amin, Hesham M.
    BLOOD, 2014, 124 (21)
  • [7] STAT1 is phosphorylated and downregulated by the oncogenic tyrosine kinase NPM-ALK in ALK-positive anaplastic large-cell lymphoma
    Wu, Chengsheng
    Molavi, Ommoleila
    Zhang, Haifeng
    Gupta, Nidhi
    Alshareef, Abdulraheem
    Bone, Kathleen M.
    Gopal, Keshav
    Wu, Fang
    Lewis, Jamie T.
    Douglas, Donna N.
    Kneteman, Norman M.
    Lai, Raymond
    BLOOD, 2015, 126 (03) : 336 - 345
  • [8] DNA AND RNA STUDIES INTO THE NPM-ALK REARRANGEMENT IN KI-1 POSITIVE ANAPLASTIC LARGE-CELL LYMPHOMA, DIAGNOSTIC APPLICATIONS
    WAGGOTT, W
    LO, YMD
    BASTARD, C
    GATTER, KC
    LEROUX, D
    MASON, DY
    BOULTWOOD, J
    WAINSCOAT, JS
    BLOOD, 1994, 84 (10) : A442 - A442
  • [9] Targeted inhibition of NPM-ALK gene expression with resultant decreased cell viability by tumor-specific small interfering RNAs in anaplastic large cell lymphoma.
    Johnston, PB
    Hsu, YY
    Tumeh, PC
    Anderson, WF
    BLOOD, 2003, 102 (11) : 25A - 25A
  • [10] The oncoprotein NPM-ALK of anaplastic large-cell lymphoma induces JUNB transcription via ERK1/2 and JunB translation via mTOR signaling
    Staber, Philipp B.
    Vesely, Paul
    Haq, Naznin
    Ott, Rene G.
    Funato, Kotaro
    Bambach, Isabella
    Fuchs, Claudia
    Schauer, Silvia
    Linkesch, Werner
    Hrzenjak, Andelko
    Dirks, Wilhelm G.
    Sexl, Veronika
    Bergler, Helmut
    Kadin, Marshall E.
    Sternberg, David W.
    Kenner, Lukas
    Hoefler, Gerald
    BLOOD, 2007, 110 (09) : 3374 - 3383
12